CD86 and neoplasm: Another modified adenovirus, LOAd 703, which encodes CD40L and 4-1BBL, has been shown to enhance cytotoxic T cell activity and inhibit tumor progression in a multiple myeloma xenograft model; it also increases tumor immunogenicity by upregulating costimulatory markers CD80 and CD86 [123,124].